News and Updates

The clinical laboratory services market is set to hit $418B by 2030. Explore the key drivers, technological advancements, and growth trends shaping this sector.

Researchers have completed the first human wireless BCI implant. Learn how this breakthrough neurotechnology could restore mobility for paralyzed patients.

A new study explores the link between 100% oxygen during deferred cord clamping and oxidative stress in newborns. Learn the clinical findings for neonatology.

Aurobindo Pharma shares remain in focus as its Eugia Steriles unit receives USFDA observations. Learn what this means for manufacturing and compliance.

Innovent Biologics has dosed the first patient in a Phase 3 trial for IBI3003, a novel tri-specific antibody for treating relapsed/refractory multiple myeloma.

The FDA is modernizing clinical trial processes through adaptive designs, digital tools, and real-world evidence to accelerate patient access to new drugs.

A new international study reveals a strategy to accurately rule out penicillin allergy, helping patients access better antibiotics and curbing AMR.

UVA Health is leading a new clinical trial targeting MAC lung disease. Discover how researchers are working to improve treatments for this chronic infection.

The CDSCO has suspended a Bengaluru hospital's ethics committee for two years due to regulatory non-compliance in clinical research oversight. Read more.

HaemaLogiX receives ethics approval for its Phase 2b KappaMab trial, targeting a breakthrough treatment option for patients with relapsed multiple myeloma.